691 Results

People

  1. De Angelis
    De Angelis
  2. Yahalom
    Yahalom
  3. Abrey
    Abrey
  4. Tallman
    Tallman
  5. Zelenetz
    Zelenetz
  6. Moskowitz
    Moskowitz
  7. Berman
    Berman
  8. Steinherz
    Steinherz
  9. Andreeff
    Andreeff
  10. Horwitz
    Horwitz

Groups

  1. Department of Medicine (359)
  2. Center for Hematologic Malignancies (304)
  3. Hematologic Malignancies, Division of (301)
  4. Adult Leukemia (134)
  5. Tow Center for Developmental Oncology (TCDO) (103)
  6. Survivorship Research (102)
  7. Lymphoma (86)
  8. Sloan Kettering Institute Faculty (82)
  9. GSK Faculty (75)
  10. Pediatrics, Department of (75)
  1. "cytarabine"
Formats
  1. Journal Article (637)
  2. Review (20)
  3. Conference Paper (19)
  4. Research Letter (6)
  5. Correspondence (3)
  6. Editorial (2)
  7. Meeting Abstract (2)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (359)
  2. Center for Hematologic Malignancies (304)
  3. Hematologic Malignancies, Division of (301)
  4. Adult Leukemia (134)
  5. Tow Center for Developmental Oncology (TCDO) (103)
  6. Survivorship Research (102)

More Groups

People
  1. Lisa De Angelis (53)
  2. Martin Tallman (42)
  3. Joachim Yahalom (39)
  4. Lauren Abrey (38)
  5. Peter Steinherz (34)
  6. Andrew Zelenetz (33)

More People

Years
  1. 2025 (15)
  2. 2024 (28)
  3. 2023 (17)
  4. 2022 (11)
  5. 2021 (9)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (45)
  2. Blood (41)
  3. Cancer (29)
  4. Leukemia (27)
  5. Bone Marrow Transplantation (25)
  6. Leukemia and Lymphoma (23)

More Publications

Publishers
  1. Elsevier Inc. (102)
  2. Nature Publishing Group (67)
  3. American Society of Hematology (52)
  4. Springer (52)
  5. American Society of Clinical Oncology (48)
  6. Lippincott Williams & Wilkins (38)

More Publishers

Results (691)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML
    Journal Article

    Wheeler, E. C.; Martin, B. J. E.; Doyle, W. C.; Neaher, S.; Conway, C. A.; Pitton, C. N.; Gorelov, R. A.; Donahue, M.; Jann, J. C.; Abdel-Wahab, O.; more...
    Science Translational Medicine (2024)

    Fulltext@MSK | Save
  • HHV-6B detection and host gene expression implicate HHV-6B as pulmonary pathogen after hematopoietic cell transplant
    Journal Article

    Hill, J. A.; Lee, Y. J.; Vande Vusse, L. K.; Xie, H.; Chung, E. L.; Waghmare, A.; Cheng, G. S.; Zhu, H.; Huang, M. L.; Hill, G. R.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: Updated recommendations by the EBMT/ELN International Working Group
    Review

    Kröger, N.; Bacigalupo, A.; Barbui, T.; Ditschkowski, M.; Gagelmann, N.; Griesshammer, M.; Gupta, V.; Hamad, N.; Harrison, C.; Hernandez-Boluda, J. C.; more...
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
    Journal Article

    Dahi, P. B.; Kenny, S.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Chinapen, S. A.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Perales, M. A.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression
    Journal Article

    Stein, E. M.; de Botton, S.; Cluzeau, T.; Pigneux, A.; Liesveld, J. L.; Cook, R. J.; Rousselot, P.; Rizzieri, D. A.; Braun, T.; Roboz, G. J.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Mature T-cell and NK-cell lymphoma involvement of the central nervous system: A single center experience
    Journal Article

    Ma, H.; Marchi, E.; O’Connor, O. A.; Lue, J. K.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Targeting apoptosis dysregulation in myeloid malignancies - The promise of a therapeutic revolution
    Review

    Santinelli, E.; Pascale, M. R.; Xie, Z.; Badar, T.; Stahl, M. F.; Bewersdorf, J. P.; Gurnari, C.; Zeidan, A. M.
    Blood Reviews (2023)

    Fulltext@MSK | Save
  • Few and far between: Clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas
    Review

    Stuver, R.; Epstein-Peterson, Z. D.; Horwitz, S. M.
    Haematologica (2023)

    Fulltext@MSK | Save
  • IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience
    Research Letter

    Gangat, N.; Ajufo, H.; Abdelmagid, M.; Karrar, O.; McCullough, K.; Badar, T.; Foran, J.; Palmer, J.; Alkhateeb, H.; Mangaonkar, A.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms
    Journal Article

    Reiner, A. S.; Durham, B. H.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V.; Abdel-Wahab, O.; Panageas, K. S.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save